Fig. 2From: ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancerLevels of ST14 in subgroups of patients with ovarian cancer. Levels of ST14 expression in ovarian cancer patients based on different (A) ages, (B) races, (C) tumor grades, (D) cancer stages, and (E) TP53 methylation statuses. OV, ovarian serous cystadenocarcinoma. *P < 0.05Back to article page